IMPL Insider Trading Activity and SEC Form 4 Filings
IMPL insider trading summary
No open-market insider purchases or sales of Impel Pharmaceuticals Inc (IMPL) have been reported on SEC Form 4 in the past 12 months.
Latest IMPL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 19, 2023 | Vivo Capital Surplus Fund VIII, L.P. | 10% Owner | Sell | $17K (208,657 @ $0.08) |
| Dec 19, 2023 | Vivo Capital Fund VIII, L.P. | 10% Owner | Sell | $17K (208,657 @ $0.08) |
| Dec 19, 2023 | Vivo Capital VIII, LLC | 10% Owner | Sell | $17K (208,657 @ $0.08) |
| Dec 19, 2023 | Vivo Capital Surplus Fund VIII, L.P. | 10% Owner | Sell | $2K (28,632 @ $0.08) |
| Dec 19, 2023 | Vivo Capital VIII, LLC | 10% Owner | Sell | $2K (28,632 @ $0.08) |
| Dec 19, 2023 | Vivo Capital Fund VIII, L.P. | 10% Owner | Sell | $2K (28,632 @ $0.08) |
| Dec 18, 2023 | Vivo Capital VIII, LLC | 10% Owner | Sell | $3K (28,682 @ $0.11) |
| Dec 18, 2023 | Vivo Capital Fund VIII, L.P. | 10% Owner | Sell | $23K (209,029 @ $0.11) |
| Dec 18, 2023 | Vivo Capital VIII, LLC | 10% Owner | Sell | $23K (209,029 @ $0.11) |
| Dec 18, 2023 | Vivo Capital Surplus Fund VIII, L.P. | 10% Owner | Sell | $3K (28,682 @ $0.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.